These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 10882412)

  • 1. Loss of CD28 expression on CD8(+) T cells is induced by IL-2 receptor gamma chain signalling cytokines and type I IFN, and increases susceptibility to activation-induced apoptosis.
    Borthwick NJ; Lowdell M; Salmon M; Akbar AN
    Int Immunol; 2000 Jul; 12(7):1005-13. PubMed ID: 10882412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD11b expression identifies CD8+CD28+ T lymphocytes with phenotype and function of both naive/memory and effector cells.
    Fiorentini S; Licenziati S; Alessandri G; Castelli F; Caligaris S; Bonafede M; Grassi M; Garrafa E; Balsari A; Turano A; Caruso A
    J Immunol; 2001 Jan; 166(2):900-7. PubMed ID: 11145666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of human CD8 T cells: implications for in vivo persistence of CD8+ CD28- cytotoxic effector clones.
    Posnett DN; Edinger JW; Manavalan JS; Irwin C; Marodon G
    Int Immunol; 1999 Feb; 11(2):229-41. PubMed ID: 10069421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV infection and aging: enhanced Interferon- and Tumor Necrosis Factor-alpha production by the CD8+ CD28- T subset.
    Eylar EH; Lefranc CE; Yamamura Y; Báez I; Colón-Martinez SL; Rodriguez N; Breithaupt TB
    BMC Immunol; 2001; 2():10. PubMed ID: 11696237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Death by neglect as a deletional mechanism of peripheral tolerance.
    Bertolino P; Trescol-Biémont MC; Thomas J; Fazekas de St Groth B; Pihlgren M; Marvel J; Rabourdin-Combe C
    Int Immunol; 1999 Aug; 11(8):1225-38. PubMed ID: 10421780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interleukin-12 restores and promotes the T-cell immune function inhibited by 5-fluorouracil].
    Chi PD; Li L; Fan YY; Wu CY
    Ai Zheng; 2007 Aug; 26(8):801-8. PubMed ID: 17697537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors that influence activated CD8+ T-cell apoptosis in patients with acute herpesvirus infections: loss of costimulatory molecules CD28, CD5 and CD6 but relative maintenance of Bax and Bcl-X expression.
    Borthwick NJ; Bofill M; Hassan I; Panayiotidis P; Janossy G; Salmon M; Akbar AN
    Immunology; 1996 Aug; 88(4):508-15. PubMed ID: 8881750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential capacities of CD4+, CD8+, and CD4-CD8- T cell subsets to express IL-18 receptor and produce IFN-gamma in response to IL-18.
    Tomura M; Maruo S; Mu J; Zhou XY; Ahn HJ; Hamaoka T; Okamura H; Nakanishi K; Clark S; Kurimoto M; Fujiwara H
    J Immunol; 1998 Apr; 160(8):3759-65. PubMed ID: 9558078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of interleukin-15 on effector and regulatory function of anti-CD3/anti-CD28-stimulated CD4(+) T cells.
    Lin SJ; Cheng PJ; Hsiao SS
    Bone Marrow Transplant; 2006 May; 37(9):881-7. PubMed ID: 16565741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-stimulation via CD28 induces activation of a refractory subset of MRL-lpr/lpr T lymphocytes.
    Clements JL; Winslow G; Donahue C; Cooper SM; Allison JP; Budd RC
    Int Immunol; 1993 Nov; 5(11):1451-60. PubMed ID: 7903158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of CD4 and CD8 engagement on the development of cytokine profiles of murine CD4+ and CD8+ T lymphocytes.
    Campbell SB; Komata T; Kelso A
    Immunology; 2000 Mar; 99(3):394-401. PubMed ID: 10712669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4⁺CD28null T lymphocytes resemble CD8⁺CD28null T lymphocytes in their responses to IL-15 and IL-21 in HIV-infected patients.
    Echeverría A; Moro-García MA; Asensi V; Cartón JA; López-Larrea C; Alonso-Arias R
    J Leukoc Biol; 2015 Sep; 98(3):373-84. PubMed ID: 26034206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD57+/CD28- T cells in untreated hemato-oncological patients are expanded and display a Th1-type cytokine secretion profile, ex vivo cytolytic activity and enhanced tendency to apoptosis.
    Van den Hove LE; Van Gool SW; Vandenberghe P; Boogaerts MA; Ceuppens JL
    Leukemia; 1998 Oct; 12(10):1573-82. PubMed ID: 9766502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary defect in CD8+ lymphocytes in the antibody deficiency disease (common variable immunodeficiency): abnormalities in intracellular production of interferon-gamma (IFN-gamma) in CD28+ ('cytotoxic') and CD28- ('suppressor') CD8+ subsets.
    North ME; Webster AD; Farrant J
    Clin Exp Immunol; 1998 Jan; 111(1):70-5. PubMed ID: 9472663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased cytolytic T lymphocyte activity and decreased B7 responsiveness are associated with CD28 down-regulation on CD8+ T cells from HIV-infected subjects.
    Vingerhoets JH; Vanham GL; Kestens LL; Penne GG; Colebunders RL; Vandenbruaene MJ; Goeman J; Gigase PL; De Boer M; Ceuppens JL
    Clin Exp Immunol; 1995 Jun; 100(3):425-33. PubMed ID: 7539725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of thymocyte development and cytokine production in CD7-deficient, CD28-deficient and CD7/CD28 double-deficient mice.
    Heinly CS; Sempowski GD; Lee DM; Patel DD; McDermott PM; Scearce RM; Thompson CB; Haynes BF
    Int Immunol; 2001 Feb; 13(2):157-66. PubMed ID: 11157849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer group 2D and CD28 receptors differentially activate mammalian/mechanistic target of rapamycin to alter murine effector CD8+ T-cell differentiation.
    McQueen B; Trace K; Whitman E; Bedsworth T; Barber A
    Immunology; 2016 Mar; 147(3):305-20. PubMed ID: 26661515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral human CD8(+)CD28(+)T lymphocytes give rise to CD28(-)progeny, but IL-4 prevents loss of CD28 expression.
    Labalette M; Leteurtre E; Thumerelle C; Grutzmacher C; Tourvieille B; Dessaint JP
    Int Immunol; 1999 Aug; 11(8):1327-36. PubMed ID: 10421790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid turnover of the CD8(+)CD28(-) T-cell subset of effector cells in the circulation of patients with head and neck cancer.
    Tsukishiro T; Donnenberg AD; Whiteside TL
    Cancer Immunol Immunother; 2003 Oct; 52(10):599-607. PubMed ID: 12827303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional dichotomy between NKG2D and CD28-mediated co-stimulation in human CD8+ T cells.
    Rajasekaran K; Xiong V; Fong L; Gorski J; Malarkannan S
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20844584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.